Introgen Therapeutics introgen.com


Introgen's objective is to be the leader in the development of molecular therapies and other products for the treatment of cancer and other diseases that, like cancer, result from cellular dysfunction and uncontrolled cell growth. Since its inception, Introgen has concentrated on product development. The Company has succeeded in initiating a broad clinical program with multiple agents in clinical development.

Introgen's objective is to be the leader in the development of molecular therapies and other products for the treatment of cancer and other diseases that, like cancer, result from cellular dysfunction and uncontrolled cell growth. Since its inception...Show all

Company (Alive / Active)

Phone:

Fax:

2250 Holcombe Blvd

Houston, 77030
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Introgen Therapeutics $30.3M Oct 1, 1997

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Introgen Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Use of mda-7 to inhibit pathogenic infectious organisms Dec 01, 2004 Oct 11, 2011 Patent
Methods for producing purified adenoviral vectors Dec 27, 2001 Mar 31, 2009 Patent